miR-223 has been detected to be upregulated in T-ALL, GC, NSCLC, and HCC in vitro and in vivo, mediating therapeutic resistance presumably through FBXW7-regulated proliferation, apoptosis, EMT, and autophagy. Here, FBXW7 is linked to non-small cell lung carcinoma.